The Pharmacologic Basis of Ifosfamide Use in Adult Patients with Advanced Soft Tissue Sarcomas
Open Access
- 1 November 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 12 (11) , 1351-1360
- https://doi.org/10.1634/theoncologist.12-11-1351
Abstract
Learning Objectives: After completing this course, the reader will be able to: Describe the current role of ifosfamide in the treatment of soft tissue sarcomas in adult patients.Discuss factors that may affect ifosfamide metabolism and its therapeutic index.Explain the advantages of ifosfamide over doxorubicin in the context of new treatment combinations.Discuss strategies to improve survival outcome in patients with soft tissue sarcoma.Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.comKeywords
This publication has 69 references indexed in Scilit:
- Using Single-Agent Therapy in Adult Patients with Advanced Soft Tissue Sarcoma Can Still Be Considered Standard CareThe Oncologist, 2005
- Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patientsEuropean Journal Of Cancer, 2002
- Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma GroupEuropean Journal Of Cancer, 2000
- Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual dataThe Lancet, 1997
- Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.Journal of Clinical Oncology, 1993
- Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.Journal of Clinical Oncology, 1987
- High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcomaCancer Chemotherapy and Pharmacology, 1983
- A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomasCancer, 1983
- A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcomaCancer, 1982
- Dose response evaluation of adriamycin in human neoplasiaCancer, 1977